Skip to main content
MeVis Medical Solutions AG logo

MeVis Medical Solutions AG — Investor Relations & Filings

Ticker · M3V ISIN · DE000A0LBFE4 LEI · 529900Z8B6L1WCLNHW14 BE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 490 across all filing types
Latest filing 2023-09-09 Governance Information
Country DE Germany
Listing BE M3V

About MeVis Medical Solutions AG

https://www.mevis.de/en/

MeVis Medical Solutions AG is a developer and provider of software for image-based medical diagnostics and therapy. The company creates innovative solutions for the analysis and processing of image data, focusing on the early detection and diagnosis of diseases, particularly in oncology. Its clinical applications target breast, lung, liver, and neurological conditions. The software supports various imaging modalities, including magnetic resonance tomography (MRT), computed tomography (CT), digital mammography, tomosynthesis, and digital sonography. MeVis markets its products to manufacturers of medical devices and medical IT platforms, offering support throughout the product lifecycle from development to integration and quality assurance. The company also provides technical visualizations for professional education, research, and publication.

Recent filings

Filing Released Lang Actions
Declaration of Conformity 2023
Governance Information Classification · 98% confidence The document is explicitly titled 'Declaration of Conformity of MeVis Medical Solutions AG with the recommendations of the "Government Commission German Corporate Governance Codex" in accordance with Section 161 of the German Stock Corporation Act (AktG)'. This type of declaration, detailing compliance or deviations from corporate governance codes, falls under governance reporting. Among the provided codes, 'Governance Information (Code: CGR)' is the most appropriate fit for a Corporate Governance Code declaration, as opposed to remuneration (DEF 14A) or general audit reports (AR). The content focuses entirely on board structure, independence, committees, and compensation philosophy relative to governance standards.
2023-09-09 English
Entsprechenserklärung 2023
Governance Information Classification · 99% confidence The document is titled "Entsprechenserklärung der MeVis Medical Solutions AG zu den Empfehlungen der 'Regierungskommission Deutscher Corporate Governance Kodex' gemäß § 161 AktG". This explicitly identifies the document as a Corporate Governance Declaration of Conformity (or Non-Conformity) statement required under German stock corporation law (§ 161 AktG) regarding the German Corporate Governance Code (DCGK). This type of report details the company's adherence to governance recommendations, covering board structure, committees, transparency, and remuneration. This aligns perfectly with the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices, distinct from a full Annual Report (10-K) or a Remuneration Report (DEF 14A). The content discusses independence of supervisory board members (C.1, C.6, C.9, C.10), committee structure (D.2, D.4), reporting deadlines (F.2), and board remuneration (G.1, G.3, G.13, G.17).
2023-09-09 German
MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year
Management Reports Classification · 99% confidence The document is an 'Ad-hoc' disclosure dated July 31, 2023, announcing an adjustment to the annual forecast for the fiscal year 2022/2023 (ending September 30, 2023). It specifically details changes in expected revenues and EBIT. This type of announcement, which provides preliminary financial updates or significant changes outside of a scheduled earnings release, is best classified as an Earnings Release (ER) if it contains key financial figures, or potentially a Regulatory Filing (RNS) if it's a general market disclosure. Since it explicitly details the revised revenue and EBIT expectations for the period, it functions as an initial announcement of financial performance changes, fitting the description of an Earnings Release (ER) more closely than a general regulatory filing, although it is technically an 'Inside Information' disclosure under MAR. Given the options, ER covers preliminary/initial financial result announcements.
2023-07-31 English
MeVis Medical Solutions AG: MeVis veroffentlicht Zahlen fur das erste Halbjahr im Geschaftsjahr 2022/2023
Earnings Release Classification · 100% confidence The document explicitly states it is announcing the 'Zahlen für das erste Halbjahr im Geschäftsjahr 2022/2023' (Figures for the first half of the fiscal year 2022/2023). It provides key financial metrics (revenue, EBIT, EBT, net income) for the six-month period (October 1, 2022, to March 31, 2023) and includes a forward-looking outlook. This content structure—a summary of financial results for a period shorter than a year—is characteristic of an Interim/Quarterly Report. Although it is presented as a news release via EQS, the core content is the financial report itself, not just an announcement of its publication (which would be RPA/RNS). Therefore, the most appropriate classification is Interim / Quarterly Report (IR). H1 2023
2023-05-25 German
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2022 bis zum 31.03.2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresfinanzbericht' (Half-Year Financial Report) for MeVis Medical Solutions AG covering the period from 01.10.2022 to 31.03.2023. It contains detailed financial statements, management discussion and analysis (Zwischenlagebericht), and operational performance data. As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. H1 2023
2023-05-25 German
Halbjahresfinanzbericht 2022/2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Zwischenbericht' (Interim Report) for MeVis Medical Solutions AG for the first half (H1) of the 2022/2023 fiscal year. It contains a management report (Vorwort des Vorstands), financial statements (Bilanz, Gewinn- und Verlustrechnung), and detailed notes (Anhang). Since it covers a period shorter than a full fiscal year and includes substantive financial data and analysis, it is classified as an Interim/Quarterly Report. H2 2023
2023-05-25 German

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.